| CRISPR THERAPEUTICS |
| Schweiz |
| Gesundheit |
| CH0334081137 / A2AT0Z |
| 1CG (Frankfurt) / CRSP (NASDAQ) |
| FRA:1CG, ETR:1CG, 1CG:GR, NASDAQ:CRSP |
| - |
| https://crisprtx.com/ |
|
Crispr Therapeutics AG is a biotechnology company specializing in the development of transformative gene-based medicines through CRISPR/Cas9 gene-editing technology. Headquartered in Zug, Switzerland,..
>Volltext.. |
| 4400.75 Mio. EUR |
| 2886.56 Mio. EUR |
| 2.98 Mio. EUR |
| -466.23 Mio. EUR |
| -493.98 Mio. EUR |
| -5.53 EUR |
| 175.6 Mio. EUR |
| 301.68 Mio. EUR |
| -293.04 Mio. EUR |
| 13.3 |
| -91.71% |
| -39.97% |
| - |
| - |
| - |
| CRISPR THERAPEUTICS |
| 26.02.26 |
|
||||
|